Tolerogenic dendritic cells (DrugBank: -)
2 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 2 |
96 | Crohn disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03337165 (ClinicalTrials.gov) | December 2016 | 3/11/2017 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | Safety/Efficacy of Intra-articular Administration of Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | Musculoskeletal Diseases;Joint Disease;Arthritis;Arthritis, Rheumatoid;Rheumatic Diseases;Connective Tissue Diseases;Autoimmune Diseases;Immune System Diseases | Biological: tolerogenic dendritic cells | Russian Academy of Medical Sciences | NULL | Completed | 18 Years | 75 Years | All | 10 | Phase 1 | Russian Federation |
2 | NCT01352858 (ClinicalTrials.gov) | February 2012 | 11/5/2011 | Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) | Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis | Rheumatoid Arthritis | Drug: TolDC;Drug: Arthroscopy & saline irrigation alone | Newcastle University | Arthritis Research UK;Newcastle-upon-Tyne Hospitals NHS Trust | Unknown status | 18 Years | N/A | All | 15 | Phase 1 | United Kingdom |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02622763 (ClinicalTrials.gov) | November 2015 | 1/12/2015 | Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment | Safety and Clinical Efficacy Evaluation of Intralesional Administration of Tolerogenic Dendritic Cells in Patients With Refractory Crohn's Disease | Crohn's Disease | Biological: Tolerogenic Dendritic Cells | Fundacion Clinic per a la Recerca Biomédica | NULL | Terminated | 18 Years | 65 Years | All | 3 | Phase 1 | Spain |